FMR LLC - REGULUS THERAPEUTICS INC ownership

REGULUS THERAPEUTICS INC's ticker is and the CUSIP is 75915K309. A total of 29 filers reported holding REGULUS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
FMR LLC ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,033,188
+24.3%
2,922,600
+32.4%
0.00%
Q2 2023$3,243,702
-12.8%
2,206,600
-49.7%
0.00%
Q1 2023$3,720,526
+23.7%
4,390,000
+100.0%
0.00%
Q4 2022$3,007,150
-19.4%
2,195,0000.0%0.00%
Q3 2022$3,732,0002,195,0000.00%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,111,049$1,522,1370.47%
Sarissa Capital Management LP 185,183$253,7010.03%
FEDERATED HERMES, INC. 3,875,578$5,348,2980.01%
PRELUDE CAPITAL MANAGEMENT, LLC 40,260$55,1560.00%
Virtu Financial LLC 25,921$360.00%
GRIMES & COMPANY, INC. 10,547$14,4490.00%
ROYAL BANK OF CANADA 80$00.00%
VANGUARD GROUP INC 285,050$390,5190.00%
VICTORY CAPITAL MANAGEMENT INC 233,207$321,8260.00%
UBS Group AG 408$5580.00%
View complete list of REGULUS THERAPEUTICS INC shareholders